Spirepoint Private Client, LLC Bristol Myers Squibb CO Transaction History
Spirepoint Private Client, LLC
- $886 Billion
- Q2 2025
A detailed history of Spirepoint Private Client, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 5,725 shares of BMY stock, worth $260,201. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,725
Previous 5,835
1.89%
Holding current value
$260,201
Previous $356 Million
25.53%
% of portfolio
0.03%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,676Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.86 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.21 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.91 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.31 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.22 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...